Transdermal testosterone administration in women with acquired immunodeficiency syndrome wasting: A pilot study

Journal of Clinical Endocrinology and Metabolism

Volumn 83, Issue 8, 1998, Pages 2717-2725

  Miller, Karen ^a   Corcoran, Colleen ^a   Armstrong, Catharina ^a   Caramelli, Kim ^d   Anderson, Ellen ^a   Cotton, Deborah ^a   Basgoz, Nesli ^a   Hirschhorn, Lisa ^c   Tuomala, Ruth ^b   Schoenfeld, David ^a   Daugherty, Claire ^d   Mazer, Norman ^d   Grinspoon, Steven ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b BRIGHAM AND WOMEN S HOSPITAL   (United States)

^c Dimock Community Health Center   (United States)

^d TheraTech Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN; TESTOSTERONE;

ADULT; ANDROGEN THERAPY; ARTICLE; CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HORMONE DEFICIENCY; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; TESTOSTERONE BLOOD LEVEL; TRANSDERMAL DRUG ADMINISTRATION; TREATMENT OUTCOME; WASTING SYNDROME; WEIGHT GAIN;

ADMINISTRATION, CUTANEOUS; ADOLESCENT; ADULT; BODY COMPOSITION; FEMALE; HIV WASTING SYNDROME; HUMANS; MENSTRUATION; MIDDLE AGED; NUTRITIONAL STATUS; PILOT PROJECTS; PLACEBOS; QUALITY OF LIFE; TESTOSTERONE; WEIGHT GAIN;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 15144360874     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.83.8.2717     Document Type: Article

References (37)

1. Kotler DP, Wang J, Pierson RN. 1985 Body composition studies in patients with the acquired immunodeficiency syndrome. Am J Clin Nutr. 42:1255-1265.
2. Kotler DP, Tierney AR, Wang J, Pierson Jr RN. 1989 Magnitude of body-cell-mass depletion and the timing of death from wasting in AIDS. Am J Clin Nutr. 50:444-447.
3. Wortley P, Fleming P. 1997 AIDS in women in the United States. JAMA. 278:911-916.
4. Grinspoon S, Corcoran C, Miller K, et al. 1997 Body composition and endocrine function in women with AIDS wasting. J Clin Endocrinol Metab. 82:1332-1337.
5. CDC. 1987 Revision of the CDC surveillance definition for acquired immunodeficiency syndrome. Morbid Mortal Weekly Rep. 36:3S-15S.
6. Mazess RB, Barden HS, Bisek JP, Hanson J. 1990 Dual-energy x-ray absorptiometry for total-body and regional bone-mineral and soft-tissue composition. Am J Clin Nutr. 51:1106-1112.
7. Lorenzo E. 1970 Clinical assessment of body hair growth in women. J Clin Endocrinol Metab. 31:556.
8. Rand Health Sciences. 1992 36-item health survey 1.0. Santa Monica: Rand Health Sciences Program.
9. Oster MH, Enders SR, Samuels SJ, et al. 1994 Megestrol acetate in patients with AIDS and cachexia. Ann Intern Med. 121:400-408.
10. Csuka M, McCarty DJ. 1984 Simple method for measurement of lower extremity muscle strength. Am J Med. 78:77-81.
11. Guyatt GH, Thompson PJ, Berman LB, et al. 1985 How should we measure function in patients with chronic heart and lung disease? J Chronic Dis. 38:517-524.
12. Podsiadlo D, Richardson S. 1991 The timed "up and go:" a test of basic functional mobility for frail elderly persons. J Am Geriatr Soc. 39:142-148.
13. Kohl HW, Blair SN, Paffenbarger RS, Macera CA, Kronenfeld JJ. 1988 A mail survey of physical activity habits as related to measured physical fitness. Am J Epidemiol. 127:1228-1239.
14. Jordan CD, Flood JG, Laposata M, Lewandrowski KB. 1992 Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Normal reference laboratory values. N Engl J Med. 327:718-724.
15. Centers for Disease Control. 1997 Update: trends in AIDS incidence, deaths and prevalence - United States, 1996. Morbid Mortal Weekly Rep. 46:165-173.
16. Schambelan M, Mulligan K, Grunfeld C, et al. 1996 Recombinant human growth hormone in patients with HIV-associated wasting. Ann Intern Med. 125:873-882.
17. Sherwin BB, Gelfand MM. 1985 Differential symptom response to parenteral estrogen and/or androgen administration in the surgical menopause. Am J Obstet Gynecol. 151:153-160.
18. Lovejoy J, Bray G, Bourgeois MO, et al. 1996 Exogenous androgens influence body composition and regional body fat distribution in obese postmenopausal women - a clinical research center study. J Clin Endocrinol Metab. 81:2198-2203.
19. Westaby D, Ogle SJ, Paradinas JF, Randell JB, Murray-Lyon IM. 1977 Liver damage from long-term methyltestosterone. Lancet. 2:262-263.
20. TheraTech, Inc. 1996 Investigator's brochure for the Theraderm testosterone matrix transdermal delivery system for women (TMTDS). Salt Lake City: TheraTech.
21. Longcope C. 1986 Adrenal and gonadal androgen secretion in normal females. Clin Endocrinol Metab. 15:213-228.
22. Southren AL, Gordon GG, Tochimoto S. 1968 Further study of the factors affecting the metabolic clearance of testosterone in man. J Clin Endocrinol Metab. 28:1105-1112.
23. Eagling V, Back D, Barry M. 1997 Differential inhibition of cytochrome P450 isoforms by the protease inhibitors, ritonavir, saquinavir and indinavir. Br J Clin Pharmacol. 44:190-194.
24. Von Roenn JH, Armstrong D, Kotler DP, et al. 1994 Megestrol acetate in patients with AIDS-related cachexia. Ann Intern Med. 121:393-399.
25. Forbes G. 1987 Lean body mass-body fat interrelationships in humans. Nutr Rev. 45:225-231.
26. Dulloo A, Jacquet J, Girardier L. 1996 Autoregulation of body composition during weight recovery in human: the Minnesota Experiment revisited. Int J Obes Relat Metab Disord. 20:393-405.
27. Gray JM, Nunez AA, Siegel LI, Wade GN. 1979 Effects of testosterone on body weight and adipose tissue: role of aromatization. Physiol Behav. 23:465-469.
28. Kochakian CD, Endahl B. 1959 Changes in body weight of normal and castrated rats by different doses of testosterone propionate. Proc Soc Exp Biol Med. 100:520-522.
29. Bhasin S, Storer TW, Herman N, et al. 1997 Testosterone replacement increases fat-free mass and muscle size in hypogonadal men. J Clin Endocrinol Metab. 82:407-413.
30. Brodsky IG, Balagopal P, Nair KS. 1996 Effects of testosterone replacement on muscle mass and muscle protein synthesis in hypogonadal men - a clinical research center study. J Clin Endocrinol Metab. 81:3469-3475.
31. Katznelson L, Finkelstein J, Schoenfeld D, Rosenthal D, Anderson E, Klibanski A. 1996 Increase in bone density and lean body mass during testosterone administration in men with acquired hypogonadism. J Clin Endocrinol Metab. 81:4358-4365.
32. Tenover JS. 1992 Effects of testosterone supplementation in the aging male. J Clin Endocrinol Metab. 75:1092-1098.
33. Urban RJ, Bodenburg YH, Gilkison C, et al. 1995 Testosterone administration to elderly men increases skeletal muscle strength and protein synthesis. Am J Physiol. 269:E820-E826.
34. Elbers JMH, Asscheman H, Seidell JC, Megens JAJ, Gooren LJG. 1997 Long-term testosterone admininistration increases visceral fat in female to male transsexuals. J Clin Endocrinol Metab. 82:2044-207.
35. Wachtel T, Piette J, Mor V, Stein M, Fleishman J, Carpenter C. 1992 Quality of life in persons with human immunodeficiency virus infection: measurement by the Medical Outcomes Study Instrument. Ann Intern Med. 116:129-137.
36. Smith MY, Feldman J, Kelly P, DeHovitz JA, Chirgwin K, Minkoff H. 1996 Health-related quality of life of HIV-infected women: evidence for the reliability, validity, and responsiveness of the Medical Outcomes Study Short-Form 20. Qual. Life Res. 5:47-55.
37. Frisch RE, McArthur JW. 1974 Menstrual cycles: fatness as a determinant of minimum weight for height necessary for their maintenance or onset. Science. 185:949-951.